MOLN
Molecular Partners AG
There isn't enough reported data to score MOLN yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
MOLN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MOLN's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MOLN PE Valuation
MOLN has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MOLN Forward outlook
There aren't enough analyst estimates for MOLN to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MOLN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$1.99 | -$0.08 |
| Q2 2025 | -$2.15 | -$0.04 |
| Q4 2024 | -$1.91 | +$0.37 |
| Q2 2024 | -$2.11 | +$0.15 |
| Q4 2023 | -$2.28 | -154% |
| Q4 2022 | $4.26 | +$6.74 |
| Q4 2021 | -$2.48 | +$0.65 |
| Q4 2020 | -$3.13 | -$1.08 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 187% for MOLN versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
MOLN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $819.8K | -81% |
| Q2 2024 | $5.2M | +24% |
| Q4 2023 | $4.3M | -29% |
| Q2 2023 | $4.2M | -98% |
| Q4 2022 | $6.1M | -48% |
| Q4 2021 | $11.7M | +531% |
| Q4 2020 | $1.9M | -55% |
| Q3 2020 | $340.7K | -92% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for MOLN versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -4315% | -3729 points |
| Q2 2024 | -742% | -822 points |
| Q4 2023 | -843% | -193 points |
| Q2 2023 | -894% | +405 points |
| Q4 2022 | -586% | +4775 points |
| Q2 2022 | 79% | +372 points |
| Q4 2021 | -650% | -329 points |
| Q4 2020 | -1299% | -944 points |
MOLN's operating margin was −4315% last quarter, down 3729 points from the same quarter a year ago, near the bottom of its range since 2016.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
MOLN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$25.6M | +$6.8M |
| Q2 2025 | -$37M | +$2.8M |
| Q4 2024 | -$32.3M | +$3.3M |
| Q2 2024 | -$39.8M | -$3.7M |
| Q4 2023 | -$35.6M | +$4.3M |
| Q2 2023 | -$36.1M | -120% |
| Q4 2022 | -$39.9M | +$70.7M |
| Q4 2021 | -$110.6M | -4638% |
UNH has the stronger cash trend. Its trailing FCF is up 5.2% versus its history, compared with MOLN at down 283%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
MOLN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +136K shares |
| 1 year | +14% | +4.5M shares |
| 3 years | +72% | +15.6M shares |
| 5 years | +77% | +16.2M shares |
| Available history | +84% | +17M shares |
MOLN has 37M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
| Q2 2019 | — |
| Q1 2019 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over MOLN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MOLN Net Leverage
MOLN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MOLN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.2 | Neutral |
| Stochastic | 4.6 | Oversold |
MOLN's weekly RSI is 30 (neutral) and its Stochastic is 5 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MOLN PE vs Healthcare Sector
| Metric | MOLN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
MOLN has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
MOLN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.64 | 17% below |
| 20 week MA | $3.94 | 24% below |
| 50 week MA | $4.15 | 27% below |
| 100 week MA | $4.15 | 27% below |
| 200 week MA | $4.79 | 37% below |
MOLN is in a downtrend: it's below all five of its weekly moving averages, and 37% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MOLN on trend strength, trading above more of its moving averages.
MOLN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $19.3 | $20.2 | +4.9% |
| 2022 | $20.2 | $6.55 | -68% |
| 2023 | $6.55 | $4.18 | -36% |
| 2024 | $4.18 | $5.30 | +27% |
| 2025 | $5.30 | $4.23 | -20% |
| 2026 YTD | $4.23 | $3.01 | -29% |
MOLN has finished lower in three of the last five years. It's down 29% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over MOLN on returns for 2026, with the stronger performance.